Oilfield Chemicals Market Size, Share, Trends, Industry Analysis Report: By Product (Rheology Modifiers, Inhibitors, and Others), By Application, By Location, and By Region – Market Forecast, 2025–2034

The oilfield chemicals market size is expected to reach USD 40.38 billion by 2034, according to a new study by Polaris Market Research. The report “Oilfield Chemicals Market Size, Share, Trends, Industry Analysis Report: By Product (Rheology Modifiers, Inhibitors, and Others), By Application, By Location, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Oilfield chemicals are specialized chemical substances used in the exploration, drilling, production, and refining of oil and gas to enhance efficiency, prevent corrosion, improve flow, and ensure safety in the oil field operations.

Rising offshore and deepwater drilling is driving the oilfield chemicals market growth. Offshore and deepwater drilling present unique challenges due to the harsh environmental conditions and high pressures involved. Specialized oilfield chemicals are necessary to ensure safe and efficient extraction of oil and gas from these extreme environments. Chemicals are used to stabilize the wellbore, prevent corrosion, and manage fluid properties during deepwater drilling. The growing interest in offshore exploration, as well as the rise in deepwater drilling activities, is increasing the demand for advanced chemicals capable of performing under these demanding conditions. This expansion in offshore and deepwater drilling activities is a key driver of the market.

The oil and gas industry is under increasing pressure to comply with environmental regulations aimed at reducing pollution, preventing spills, and mitigating adverse environmental impacts. As a result, there is a growing demand for more eco-friendly oilfield chemicals. These chemicals, often biodegradable and nontoxic, help companies meet regulatory requirements while maintaining operational efficiency. The shift toward sustainable practices in the oil and gas sector is encouraging the use of environmentally responsible chemicals, creating opportunities for the development and adoption of green technologies in the market.

Oilfield Chemicals Market Report Highlights

In 2024, based on product, the rheology modifiers segment dominated the oilfield chemicals market, as rheology modifiers play a major role in modifying the rheological properties of oil wells.

The workover & completion segment, by application, is expected to witness significant growth during the forecast period attributed to the utilization of workover and completion chemicals by oil companies post-oil extraction from wells.

In 2024, North America dominated the market as the US and Canada comprise a robust offshore oil and gas industry, with Canada ranking as the world's fourth-largest producer of crude oil.

The Asia Pacific market is expected to record the highest CAGR during the forecast period, driven by increasing exploration and production activities in offshore and onshore oil and gas fields.

A few global key market players are Nouryon, BASF SE, SMC Global, Baker Hughes, Halliburton, The Lubrizol Corporation, Aquapharm Chemical Pvt. Ltd., Clariant, Solvay S.A., and Thermax Chemical Division.

Polaris Market Research has segmented the oilfield chemicals market report on the basis of product, application, location, and region:

By Product Outlook (Revenue, USD Billion; 2020–2034)

Inhibitors

Demulsifiers

Rheology Modifiers

Friction Reducers

Biocides

Surfactants

Foamers

Others

By Application Outlook (Revenue, USD Billion; 2020–2034)

Drilling

Production

Cementing

Workover & Completion

By Location Outlook (Revenue, USD Billion; 2020–2034)

Onshore

Offshore

By Regional Outlook (Revenue, USD Billion; 2020–2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. Global Nucleic Acid Amplification Testing Market Insights
4.1. Nucleic Acid Amplification Testing Market – Market Snapshot
4.2. Nucleic Acid Amplification Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Global Prevalence of Infectious Diseases
4.2.1.2. Increasing Incidence of Genetic Disorders
4.2.2. Restraints and Challenges
4.2.2.1. High cost and need for specialized equipment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Nucleic Acid Amplification Testing Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Nucleic Acid Amplification Testing Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
5.3. PCR Tests
5.3.1. Global Nucleic Acid Amplification Testing Market, by PCR Tests, by Region, 2020–2034 (USD Billion)
5.4. INAAT Tests
5.4.1. Global Nucleic Acid Amplification Testing Market, by INAAT Tests, by Region, 2020–2034 (USD Billion)
5.5. LCR Tests
5.5.1. Global Nucleic Acid Amplification Testing Market, by LCR Tests, by Region, 2020–2034 (USD Billion)
6. Global Nucleic Acid Amplification Testing Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
6.3. Infectious Disease Testing
6.3.1. Global Nucleic Acid Amplification Testing Market, by Infectious Disease Testing, by Region, 2020–2034 (USD Billion)
6.4. Deep Tensor
6.4.1. Global Nucleic Acid Amplification Testing Market, by Deep Tensor, by Region, 2020–2034 (USD Billion)
6.5. Oncology Testing
6.5.1. Global Nucleic Acid Amplification Testing Market, by Oncology Testing, by Region, 2020–2034 (USD Billion)
6.6. Genetic & Mitochondrial Disease Testing
6.6.1. Global Nucleic Acid Amplification Testing Market, by Genetic & Mitochondrial Disease Testing, by Region, 2020–2034 (USD Billion)
6.7. Others
6.7.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020–2034 (USD Billion)
7. Global Nucleic Acid Amplification Testing Market, by End Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
7.3. Hospitals
7.3.1. Global Nucleic Acid Amplification Testing Market, by Hospitals, by Region, 2020–2034 (USD Billion)
7.4. Central
7.4.1. Global Nucleic Acid Amplification Testing Market, by Central, by Region, 2020–2034 (USD Billion)
7.5. Reference Laboratories
7.5.1. Global Nucleic Acid Amplification Testing Market, by Reference Laboratories, by Region, 2020–2034 (USD Billion)
7.6. Others
7.6.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020–2034 (USD Billion)
8. Global Nucleic Acid Amplification Testing Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Nucleic Acid Amplification Testing Market Assessment, By Geography, 2020–2034 (USD Billion)
8.3. Nucleic Acid Amplification Testing Market – North America
8.3.1. North America: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.3.2. North America: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.3.3. North America: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.3.4. Nucleic Acid Amplification Testing Market – U.S.
8.3.4.1. U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.3.4.2. U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.3.4.3. U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.3.5. Nucleic Acid Amplification Testing Market – Canada
8.3.5.1. Canada: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.3.5.2. Canada: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.3.5.3. Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4. Nucleic Acid Amplification Testing Market – Europe
8.4.1. Europe: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.2. Europe: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.3. Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4.4. Nucleic Acid Amplification Testing Market – UK
8.4.4.1. UK: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.4.2. UK: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.4.3. UK: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4.5. Nucleic Acid Amplification Testing Market – France
8.4.5.1. France: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.5.2. France: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.5.3. France: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4.6. Nucleic Acid Amplification Testing Market – Germany
8.4.6.1. Germany: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.6.2. Germany: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.6.3. Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4.7. Nucleic Acid Amplification Testing Market – Italy
8.4.7.1. Italy: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.7.2. Italy: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.7.3. Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4.8. Nucleic Acid Amplification Testing Market – Spain
8.4.8.1. Spain: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.8.2. Spain: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.8.3. Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4.9. Nucleic Acid Amplification Testing Market – Netherlands
8.4.9.1. Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.9.2. Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.9.3. Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4.10. Nucleic Acid Amplification Testing Market – Russia
8.4.10.1. Russia: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.10.2. Russia: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.10.3. Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.4.11. Nucleic Acid Amplification Testing Market – Rest of Europe
8.4.11.1. Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.4.11.2. Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.4.11.3. Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5. Nucleic Acid Amplification Testing Market – Asia Pacific
8.5.1. Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.2. Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.3. Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5.4. Nucleic Acid Amplification Testing Market – China
8.5.4.1. China: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.4.2. China: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.4.3. China: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5.5. Nucleic Acid Amplification Testing Market – India
8.5.5.1. India: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.5.2. India: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.5.3. India: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5.6. Nucleic Acid Amplification Testing Market – Malaysia
8.5.6.1. Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.6.2. Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.6.3. Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5.7. Nucleic Acid Amplification Testing Market – Japan
8.5.7.1. Japan: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.7.2. Japan: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.7.3. Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5.8. Nucleic Acid Amplification Testing Market – Indonesia
8.5.8.1. Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.8.2. Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.8.3. Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5.9. Nucleic Acid Amplification Testing Market – South Korea
8.5.9.1. South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.9.2. South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.9.3. South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5.10. Nucleic Acid Amplification Testing Market – Australia
8.5.10.1. Australia: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.10.2. Australia: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.10.3. Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.5.11. Nucleic Acid Amplification Testing Market – Rest of Asia Pacific
8.5.11.1. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.5.11.2. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.5.11.3. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.6. Nucleic Acid Amplification Testing Market – Middle East & Africa
8.6.1. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.6.2. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.6.3. Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.6.4. Nucleic Acid Amplification Testing Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.6.4.2. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.6.4.3. Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.6.5. Nucleic Acid Amplification Testing Market – UAE
8.6.5.1. UAE: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.6.5.2. UAE: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.6.5.3. UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.6.6. Nucleic Acid Amplification Testing Market – Israel
8.6.6.1. Israel: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.6.6.2. Israel: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.6.6.3. Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.6.7. Nucleic Acid Amplification Testing Market – South Africa
8.6.7.1. South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.6.7.2. South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.6.7.3. South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.6.8. Nucleic Acid Amplification Testing Market – Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.6.8.2. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.6.8.3. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.7. Nucleic Acid Amplification Testing Market – Latin America
8.7.1. Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.7.2. Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.7.3. Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.7.4. Nucleic Acid Amplification Testing Market – Mexico
8.7.4.1. Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.7.4.2. Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.7.4.3. Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.7.5. Nucleic Acid Amplification Testing Market – Brazil
8.7.5.1. Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.7.5.2. Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.7.5.3. Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.7.6. Nucleic Acid Amplification Testing Market – Argentina
8.7.6.1. Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.7.6.2. Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.7.6.3. Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
8.7.7. Nucleic Acid Amplification Testing Market – Rest of Latin America
8.7.7.1. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020–2034 (USD Billion)
8.7.7.2. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020–2034 (USD Billion)
8.7.7.3. Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020–2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Agilent Technologies, Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Becton, Dickinson and Company (BD)
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. bioMérieux S.A.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Danaher Corporation (Cepheid)
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. F. Hoffmann-La Roche AG
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Hologic, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Illumina, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. QIAGEN N.V.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Siemens Healthineers AG
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Thermo Fisher Scientific Inc.
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings